Study for continued access to dacomitinib for patients previously treated with dacomitinib in clinical studies in Japan

Treatment Access Protocol for Patients Previously Treated With Dacomitinib on a Clinical Trial in Japan

Category & Conditions:
Cancer
Medicine:
VIZIMPRO® TABLETS(DACOMITINIB)
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
A7471055
Open Plain Language Summary Result:Click here